Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation.
Koehl
G
G
Department of Surgery, University of Regensburg, Regensburg, Germany.
Guba
M
M
Seeliger
H
H
Steinbauer
M
M
Anthuber
M
M
Jauch
K-W
KW
Geissler
E K
EK
D000230:Adenocarcinoma / Q000098:blood supply / Q000188:drug therapy; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D004195:Disease Models, Animal; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D020123:Sirolimus / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D020123:Sirolimus